Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2013
06/20/2013WO2013090278A2 Intranasal dexmedetomidine compositions and methods of use thereof
06/20/2013WO2013089835A1 Composition and method for treating nucleic acid-related eye disease
06/20/2013WO2013089833A1 Long-lasting easy wash-off cosmetic compositions
06/20/2013WO2013089689A1 Constituent of desmodium elegans and methods of use
06/20/2013WO2013089656A1 Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
06/20/2013WO2013089654A1 Effervescent formulations comprising genistein
06/20/2013WO2013089522A1 Novel oligonucleotide conjugates and use thereof
06/20/2013WO2013089493A1 Anti-adhesive composition, surgical mesh complex containing same for anti-adhesion functions, and method for manufacturing same
06/20/2013WO2013089489A1 Orally disintegrating tablet, and method for preparing same
06/20/2013WO2013089479A1 Solid dispersion containing celecoxib, and method for preparing same
06/20/2013WO2013089461A1 Massage patch having fine protrusions and comprising fibers, and method for manufacturing same
06/20/2013WO2013089411A1 Gene nanocomposite, and cellular internalization method of gene using same
06/20/2013WO2013089394A2 Composition of an aqueous solution of polymeric nanoparticles and method for preparing same
06/20/2013WO2013089152A1 Lipid nanoparticles containing combinations of cationic lipids
06/20/2013WO2013089151A1 Lipid nanoparticles for drug delivery system containing cationic lipids
06/20/2013WO2013089140A1 Method for producing antimicrobial composition
06/20/2013WO2013088389A1 Linezolid premix
06/20/2013WO2013088381A1 Gel compositions
06/20/2013WO2013088380A1 Gel compositions
06/20/2013WO2013088379A1 A topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
06/20/2013WO2013088376A1 Gel compositions
06/20/2013WO2013088375A1 A topical composition comprising an ingenol derivative and an oily solvent
06/20/2013WO2013088274A1 Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
06/20/2013WO2013088272A1 Pharmaceutical composition comprising esomeprazole magnesium dihydrate
06/20/2013WO2013088271A1 Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan
06/20/2013WO2013088254A1 Transdermal delivery system comprising buprenorphine
06/20/2013WO2013088250A1 Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
06/20/2013WO2013088230A1 Composition for electronic cigarettes
06/20/2013WO2013088161A1 Sublingual administration of statins
06/20/2013WO2013087920A1 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
06/20/2013WO2013087903A1 Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
06/20/2013WO2013087815A1 Liquid pharmaceutical composition containing a pyrazolopyrimidine derivative and pharmaceutical uses thereof
06/20/2013WO2013087808A1 Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
06/20/2013WO2013087804A1 Improvements in and relating to electroosmotic pumps
06/20/2013WO2013087660A1 Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
06/20/2013WO2013087563A1 Pharmaceutical composition comprising (s)-2-(2-oxopyrrolidin-1-yl)butanamid
06/20/2013WO2013087546A1 Pharmaceutical composition with improved bioavailability for high melting hydrophobic compound
06/20/2013WO2013087410A1 Treatment of migraine headaches, in particular cluster headaches
06/20/2013WO2013087083A1 Particles comprising single stranded rna and double stranded rna for immunomodulation
06/20/2013WO2013057741A3 Pharmaceutical compositions of ursodeoxycholic acid
06/20/2013WO2013049068A8 Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrombogenic agent
06/20/2013WO2012094381A3 Spray drying vancomycin
06/20/2013WO2012034201A3 Creatine-containing food supplement composition, method for preparing same and food supplement dosage form
06/20/2013US20130158120 Stable pharmaceutical composition and methods of using same
06/20/2013US20130158119 Pharmaceutical semi-solid composition of isotretinoin
06/20/2013US20130158092 New Oral Formulation
06/20/2013US20130158061 Controlled release hydrocodone
06/20/2013US20130157992 Sustained drug release and improved product stability using non-covalent particle coating methods
06/20/2013US20130157937 Stable high lipid liquid formula
06/20/2013US20130156934 Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer
06/20/2013US20130156871 Nasal Wash Solution
06/20/2013US20130156858 Formulations Preserving Bioactivity and Methods of Their Preparation
06/20/2013US20130156856 Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof
06/20/2013US20130156855 Acne treatment
06/20/2013US20130156852 Stable pharmaceutical composition and methods of using same
06/20/2013US20130156849 Modified nucleoside, nucleotide, and nucleic acid compositions
06/20/2013US20130156845 Lipid formulated single stranded rna
06/20/2013US20130156842 Bioadhesive drug formulations for oral transmucosal delivery
06/20/2013US20130156841 Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids
06/20/2013US20130156840 Implantable intraocular drug delivery apparatus, system and method
06/20/2013US20130156832 Eudermic compositions
06/20/2013US20130156827 Sodium alginate crosslinked slow-release moxifloxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere
06/20/2013US20130156825 Modafinil Formulations
06/20/2013US20130156823 Excipient-free Aerosol Formulation
06/20/2013US20130156822 Drug delivery system and method for the treatment of neuro-degenerative disease
06/20/2013US20130156818 Methods and compositions for controlling assembly of viral proteins
06/20/2013US20130156815 Transdermal estrogen device and delivery
06/20/2013US20130156812 Composition of Antigen and Method of Sublingual Administration
06/20/2013US20130156749 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
06/20/2013US20130156712 Stable surfactant compositions for suspending components
06/20/2013US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/20/2013DE102012102218A1 Ozon nicht abbauende medizinische Aerosolformulierungen Ozone depleting non medical aerosol formulations
06/20/2013DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production
06/20/2013DE102006044447B4 Gelartiges Basenpräparat auf Basis ätherischer Ölmischungen zur dermalen und transdermalen Anwendung Gel-base preparation based on essential oil blends for dermal and transdermal application
06/20/2013CA2858593A1 Use of polymeric excipients for lyophilization or freezing of particles
06/20/2013CA2858531A1 Transdermal delivery system comprising buprenorphine
06/20/2013CA2858315A1 Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
06/20/2013CA2857337A1 Compositions containing kinase inhibitors
06/20/2013CA2857260A1 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
06/20/2013CA2850706A1 Pharmaceutical composition with improved bioavailability for high melting hydrophobic compound
06/19/2013EP2604686A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection
06/19/2013EP2604621A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604364A1 Composition comprising nanoparticles and a method for the preparation thereof
06/19/2013EP2604287A2 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604286A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604285A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604266A1 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
06/19/2013EP2604257A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
06/19/2013EP2604256A1 Multi layer coatings
06/19/2013EP2604255A1 Novel reagents for transfection of eukaryotic cells
06/19/2013EP2603520A2 Erythrocyte-binding therapeutics
06/19/2013EP2603450A1 Yeast cell wall particle for receptor-targeted nanoparticle delivery
06/19/2013EP2603288A1 Pharmaceutical granulate comprising imatinib mesylate
06/19/2013EP2603247A2 Fibrin based scaffold, preparation and use thereof
06/19/2013EP2603246A2 Method and system for reversal of interactions between hydrophobically modified biopolymers and vesicles or cell membranes
06/19/2013EP2603238A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
06/19/2013EP2603209A2 Structures for transdermal drug delivery
06/19/2013EP2603207A2 Oral controlled release pharmaceutical compositions of blonanserin
06/19/2013EP2603206A2 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
06/19/2013EP2603205A2 Use of binders for manufacturing storage stable formulations
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 2991